J&J snaps of Abbott’s eye unit for $4.36bn
Johnson & Johnson is buying Abbott’s eye health unit in a cash deal worth $4.36 billion, building on its presence in the area and marking its entry into cataract surgery.
Read More
Tag: eye health
- Nuclera and leadXpro partner to accelerate structure‑based drug design
- Lundbeck reports positive phase 2b results for migraine prevention drug
- European life sciences coalition launched to boost investment ecosystem
- 99mtc‑maraciclatide granted fast track status for ILD imaging
- Bioxytran reports rapid viral clearance in phase 2 trial
